iGMDRD50
Canonical SMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O
InChI: InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1
InChI Key: UHDGCWIWMRVCDJ-CCXZUQQUSA-N
Drug Class:
Anti-Infective AgentsAntimetabolitesAntimetabolites, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsAntiviral AgentsArabinonucleosidesCarbohydratesCardiotoxic antineoplastic agentsCytidineGlycosidesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunologic FactorsImmunosuppressive AgentsMyelosuppressive AgentsNoxaeNucleic Acids, Nucleotides, and NucleosidesNucleoside Metabolic InhibitorNucleosidesP-glycoprotein/ABCB1 SubstratesPyrimidine AnaloguesPyrimidine NucleosidesPyrimidinesRibonucleosidesToxic ActionsDrug Pathways:
DNA replicationDrug Synonyms:
Cytarabine hydrochloride (USAN)Drug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Cytarabine
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |